Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has informed the stock exchanges that its trading window will remain closed for insiders, directors, promoters, designated persons, and their immediate relatives starting Wednesday, October 1, 2025. The closure will last until 48 hours after the company declares its unaudited financial results for the second quarter and half year ended September 30, 2025. This is a standard compliance measure under SEBI's Insider Trading Regulations to prevent trading on unpublished price-sensitive information ahead of the earnings announcement. The company has also designated CDSL to freeze PANs of designated persons at the ISIN level to enforce trading restrictions. The exact date of the board meeting to approve the Q2 results has not yet been announced.
This is a routine regulatory filing and does not directly affect shareholders. However, it signals that the company's Q2 FY26 earnings announcement is approaching, which may bring volatility or movement based on the results.